Earlier assessment of response to TACE therapy

Volumetric functional MR assessment is documented to predict TACE therapy response after one month1, where the currently available imaging criteria (morphology-based) assess therapy response after six months, earliest2.

The benefits are two-fold: Treatment path optimization and savings of unnecessary treatment costs.